Cargando…

Monitoring of omalizumab therapy in children and adolescents

Background: Omalizumab is a successfully implemented supplementary therapy for improving asthma control in children aged 6 years and older with severe persistent allergic asthma. The dosage of omalizumab depends on body weight and IgE level, yet no parameter has been established to guide dosage chan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steiß, J.O., Schmidt, A., Lindemann, H., Rudloff, S., Staatz, A., Strohner, P., Becher, G. , Nährlich, L., Zimmer, K.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881852/ https://www.ncbi.nlm.nih.gov/pubmed/31826035 http://dx.doi.org/10.5414/ALX01337E

Ejemplares similares

Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)

In search of clinically relevant parameters to monitor successful omalizumab therapy in allergic asthma
por: Probst, M., et al.
Publicado: (2019)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
por: De Castro, Giovanna, et al.
Publicado: (2013)

Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
por: Giovannini, Mattia, et al.
Publicado: (2019)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland
por: Sztafińska, Anna, et al.
Publicado: (2021)

Long term treatment with omalizumab in adolescent with refractory solar urticaria
por: Iannelli, Mauro, et al.
Publicado: (2021)

PD11 - Omalizumab in children: experience in the Immunoallergology Department
por: Aguiar, Rita, et al.
Publicado: (2014)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring
por: Nilsson, Caroline, et al.
Publicado: (2014)

Omalizumab—A Review
por: Godse, Kiran, et al.
Publicado: (2015)

Omalizumab therapy in three patients with chronic autoimmune urticaria
por: Al-Ahmad, Mona
Publicado: (2010)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
por: Cruz, A A, et al.
Publicado: (2007)

A clinical follow‐up of omalizumab in routine treatment of allergic asthma monitored by CD‐sens
por: Johansson, S. Gunnar O., et al.
Publicado: (2018)

Omalizumab as a new therapeutic approach for children with severe asthma
por: Jerzyńska, Joanna, et al.
Publicado: (2014)

Omalizumab in children with severe allergic disease: a case series
por: Crisafulli, Giuseppe, et al.
Publicado: (2019)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
por: Barrios, Jonathan Lacombe, et al.
Publicado: (2011)

Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Omalizumab Has a Place in Therapy for Asthma Disease Management
por: Pesko, Lawrence J.
Publicado: (2009)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Sex, Allergic Diseases and Omalizumab
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Treatment of estrogen-induced dermatitis with omalizumab
por: Ocana, Jesus A., et al.
Publicado: (2019)

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
por: Wood, Robert A., et al.
Publicado: (2022)

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet
por: Pena Peloche, María, et al.
Publicado: (2011)

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience
por: Licari, Amelia, et al.
Publicado: (2017)

Omalizumab and unmet needs in severe asthma and allergic comorbidities in Japanese children
por: Nishima, Sankei, et al.
Publicado: (2019)

Omalizumab for the treatment of severe allergic asthma in children: A tale of two
por: Brannick, Sinéad, et al.
Publicado: (2022)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Evaluation of Omalizumab From a Health Plan Perspective
por: Belliveau, Paul P., et al.
Publicado: (2005)

Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease
por: Barni, Simona, et al.
Publicado: (2021)

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment
por: Wang, Mei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u9svnohgtjq0tac70plfqqvcp9